Comment

COMMENT 1 ESRR.html

Postmarketing Safety Reports for Human Drug and Biological Products: Electronic Submission Requirements - Final Rule

Comment

OMB: 0910-0770

Document [html]
Download: html


PUBLIC SUBMISSION

As of: 6/9/14 1:48 PM
Received: August 21, 2009
Status: Posted
Posted: August 24, 2009
Category: Academia - E0007
Tracking No. 80a0fb4c
Comments Due: November 19, 2009
Submission Type: Web

Docket: FDA-2008-N-0334
Postmarketing Safety Reports for Human Drug and Biological Products: Electronic Submission Requirements

Comment On: FDA-2008-N-0334-0001
Postmarketing Safety Reports for Human Drug and Biological Products; Electronic Submission Requirements

Document: FDA-2008-N-0334-0002
jean public - Comment


Submitter Information

Name: jean public
Address: United States, 
Organization: n/a

General Comment

all persons who have adverse reactions should submit comments on their adverse reactions. it should be a secure system that big pharma profiteers cannot alter by hacking or by any other method. we do not want corrupt, untruthful reports. we want an accurate accounting of what happens when a person takes a drug. it is clear that the side effects of most drugs are not properly conveyed to drug takers.

File Typetext/html
File Modified0000-00-00
File Created0000-00-00

© 2024 OMB.report | Privacy Policy